Literature DB >> 15168021

The time has come to target connective tissue growth factor in diabetic complications.

S M Twigg1, M E Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15168021     DOI： 10.1007/s00125-004-1423-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  29 in total

Review 1.  Connective tissue growth factor: just another factor in renal fibrosis?

Authors:  R Goldschmeding; J Aten; Y Ito; I Blom; T Rabelink; J J Weening
Journal:  Nephrol Dial Transplant       Date:  2000-03       Impact factor: 5.992

2.  Expression of connective tissue growth factor in human renal fibrosis.

Authors:  Y Ito; J Aten; R J Bende; B S Oemar; T J Rabelink; J J Weening; R Goldschmeding
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

3.  Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo.

Authors:  T Shimo; T Nakanishi; T Nishida; M Asano; M Kanyama; T Kuboki; T Tamatani; K Tezuka; M Takemura; T Matsumura; M Takigawa
Journal:  J Biochem       Date:  1999-07       Impact factor: 3.387

4.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Authors:  F N Ziyadeh; B B Hoffman; D C Han; M C Iglesias-De La Cruz; S W Hong; M Isono; S Chen; T A McGowan; K Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

Authors:  S Wang; M Denichilo; C Brubaker; R Hirschberg
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

6.  The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.

Authors:  C C Chen; N Chen; L F Lau
Journal:  J Biol Chem       Date:  2000-12-18       Impact factor: 5.157

Review 7.  Diabetic nephropathy: renal development gone awry?

Authors:  Vincent Dolan; Carmel Hensey; Hugh R Brady
Journal:  Pediatr Nephrol       Date:  2002-11-22       Impact factor: 3.714

8.  Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

Authors:  José G Abreu; Nan I Ketpura; Bruno Reversade; E M De Robertis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

9.  Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration.

Authors:  Ryoichi Mori; Toshikazu Kondo; Tohru Ohshima; Yuko Ishida; Naofumi Mukaida
Journal:  FASEB J       Date:  2002-07       Impact factor: 5.191

10.  Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria?

Authors:  Sharon G Adler; Shin-Wook Kang; Stella Feld; Dae Ryong Cha; Lilly Barba; Liliane Striker; Gary Striker; Bruce L Riser; Janine LaPage; Cynthia C Nast
Journal:  Am J Kidney Dis       Date:  2002-07       Impact factor: 8.860
View more
  16 in total

Review 1.  Antiproteinuric effect of RAS blockade: new mechanisms.

Authors:  Markus Lassila; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Curr Hypertens Rep       Date:  2004-10       Impact factor: 5.369

2.  Mastering a mediator: blockade of CCN-2 shows early promise in human diabetic kidney disease.

Authors:  Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2010-10-19       Impact factor: 5.782

3.  Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy.

Authors:  Amy Jayne McKnight; David A Savage; Chris C Patterson; Hugh R Brady; A Peter Maxwell
Journal:  J Hum Genet       Date:  2006-02-24       Impact factor: 3.172

Review 4.  What are new avenues for renal protection, in addition to RAAS inhibition?

Authors:  Shinji Hagiwara; Phillip Kantharidis; Mark E Cooper
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

5.  CTGFsiRNA ameliorates retinal cells apoptosis in streptozotocin-induced diabetic rats.

Authors:  Hong-Wei Yang; Xiao-Long Chen; Zhe-Li Liu; Jie Liu; Li-Min Bu
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

6.  Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.

Authors:  Arthur C K Chung; Haiyan Zhang; Yao-Zhong Kong; Jia-Ju Tan; Xiao R Huang; Jeffrey B Kopp; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

7.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

8.  A novel primate model of delayed wound healing in diabetes: dysregulation of connective tissue growth factor.

Authors:  S E Thomson; S V McLennan; A Hennessy; P Boughton; J Bonner; H Zoellner; D K Yue; S M Twigg
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

9.  Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis.

Authors:  Y Pham; Y Tu; T Wu; T J Allen; A C Calkin; A M Watson; J Li; K A Jandeleit-Dahm; B-H Toh; Z Cao; M E Cooper; Z Chai
Journal:  Diabetologia       Date:  2009-10-22       Impact factor: 10.122

Review 10.  Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?

Authors:  Tri Q Nguyen; Roel Goldschmeding
Journal:  Pharm Res       Date:  2008-02-12       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.